Related Experiment Video
Updated: Dec 12, 2025
09:48
Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance
Published on: February 17, 2023
3.3K
Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin
Yoshihiro Kamada1, Shinji Tamura, Shinichi Kiso
1Department of Internal Medicine and Molecular Science, Osaka University, Graduate School of Medicine, Suita, Japan.
Gastroenterology
|January 16, 2004
Summary
Adiponectin, an adipocytokine, shows potential in preventing liver fibrosis. Studies in mice and cell cultures demonstrate adiponectin
Area of Science:
- Hepatology and Metabolic Research
- Adipokine Signaling Pathways
Background:
- Obesity is a risk factor for liver fibrosis, associated with decreased plasma adiponectin levels.
- Hepatic stellate cells are key players in liver fibrosis, activating into myofibroblast-like cells.
- Adiponectin's known effects on vascular smooth muscle cells suggest a role in liver fibrosis.
Purpose of the Study:
- To investigate the role of adiponectin in carbon tetrachloride-induced liver fibrosis.
- To evaluate the therapeutic potential of adiponectin in liver fibrosis models.
Main Methods:
- Utilized adiponectin-knockout mice and wild-type mice treated with carbon tetrachloride.
- Employed an adenovirus-mediated adiponectin expression system (AdADN) for therapeutic intervention.
- Assessed adiponectin's effects on cultured activated hepatic stellate cells.
Main Results:
- Adiponectin-knockout mice exhibited more severe liver fibrosis compared to controls.
- Adiponectin administration significantly prevented liver fibrosis development and attenuated existing fibrosis.
- Adiponectin suppressed hepatic stellate cell proliferation, migration, and TGF-β1 signaling.
Conclusions:
- Adiponectin demonstrates a protective effect against liver fibrosis.
- Adiponectin represents a potential novel therapeutic strategy for liver fibrosis prevention and treatment.
